Study shows why a common form of immunotherapy fails, and suggests solution

by Georgetown University Medical CenterSamir N. Khleif, MD, director of The Loop Immuno-Oncology Laboratory at Georgetown Lombardi, led the research team that published new research on checkpoint

Updated on: March 01,2024

Study shows why a common form of immunotherapy fails, and suggests solution

by Georgetown University Medical CenterSamir N. Khleif, MD, director of The Loop Immuno-Oncology Laboratory at Georgetown Lombardi, led the research team that published new research on checkpoint

Updated on:March 01,2024

Study: Anti-PD-L1 antibody enhances curative effect of cryoablation

by Compuscript LtdGraphical abstract. Credit:Acta Pharmaceutica Sinica B(2022). DOI: 10.1016/j.apsb.2022.08.006A new article published inActa Pharmaceutica Sinica Bdiscusses ho

Updated on: January 30,2024

Study: Anti-PD-L1 antibody enhances curative effect of cryoablation

by Compuscript LtdGraphical abstract. Credit:Acta Pharmaceutica Sinica B(2022). DOI: 10.1016/j.apsb.2022.08.006A new article published inActa Pharmaceutica Sinica Bdiscusses ho

Updated on:January 30,2024

Researchers are building detailed maps of colorectal cancer to better understand the dynamics of the disease

by Harvard Medical SchoolA 3D reconstruction of colorectal cancer revealed that what was once thought to be 2D mucin pools with clusters of cancer cells floating inside is actually a complex and

Updated on: February 24,2024

Researchers are building detailed maps of colorectal cancer to better understand the dynamics of the disease

by Harvard Medical SchoolA 3D reconstruction of colorectal cancer revealed that what was once thought to be 2D mucin pools with clusters of cancer cells floating inside is actually a complex and

Updated on:February 24,2024

Investigators reveal changes to immune status in patient tumors after radiation

by Roswell Park Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainLittle is known about how radiation therapy to kill cancer cells affects immune cells and other components of patient tumors

Updated on: January 30,2024

Investigators reveal changes to immune status in patient tumors after radiation

by Roswell Park Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainLittle is known about how radiation therapy to kill cancer cells affects immune cells and other components of patient tumors

Updated on:January 30,2024

Everolimus inhibits angiogenesis and lymphangiogenesis in TP53 mutant HNSCC via STAT3/HIF-1α/VEGF pathway

by Impact Journals LLCEverolimus reduces microvessel density (MVD) and lymphatic vessel density (LVD) in TP53 mutant HNSCC xenografts. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.283

Updated on: February 03,2024

Everolimus inhibits angiogenesis and lymphangiogenesis in TP53 mutant HNSCC via STAT3/HIF-1α/VEGF pathway

by Impact Journals LLCEverolimus reduces microvessel density (MVD) and lymphatic vessel density (LVD) in TP53 mutant HNSCC xenografts. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.283

Updated on:February 03,2024

Drug compound could be next-generation treatment for aggressive form of leukemia

by Tom Coyne,Purdue UniversityHerman Sintim, the Drug Discovery Professor of Chemistry in Purdue University's Department of Chemistry, is leading a team of researchers developing a series of

Updated on: May 25,2024

Drug compound could be next-generation treatment for aggressive form of leukemia

by Tom Coyne,Purdue UniversityHerman Sintim, the Drug Discovery Professor of Chemistry in Purdue University's Department of Chemistry, is leading a team of researchers developing a series of

Updated on:May 25,2024

Researchers share insights on the evolution of proton radiotherapy

by Mass General BrighamCredit: Unsplash/CC0 Public DomainIn a review article published inThe Lancet Oncology, Susu Yan, Ph.D., and Thomas Bortfeld, Ph.D., from the Biophysics Division of MG

Updated on: February 01,2024

Researchers share insights on the evolution of proton radiotherapy

by Mass General BrighamCredit: Unsplash/CC0 Public DomainIn a review article published inThe Lancet Oncology, Susu Yan, Ph.D., and Thomas Bortfeld, Ph.D., from the Biophysics Division of MG

Updated on:February 01,2024

Epigenetic age and lung cancer risk in a prospective cohort study

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainEpigenetic age, a robust marker of biological aging, has been associated with obesity, low-grade inflammation and metabolic diseases. However, fe

Updated on: February 03,2024

Epigenetic age and lung cancer risk in a prospective cohort study

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainEpigenetic age, a robust marker of biological aging, has been associated with obesity, low-grade inflammation and metabolic diseases. However, fe

Updated on:February 03,2024

Researchers develop new one-two punch against melanoma in mouse model

by Johns Hopkins University School of MedicineCredit: Kimmel Cancer CenterResearchers at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins and the Johns Hopkins University

Updated on: June 04,2024

Researchers develop new one-two punch against melanoma in mouse model

by Johns Hopkins University School of MedicineCredit: Kimmel Cancer CenterResearchers at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins and the Johns Hopkins University

Updated on:June 04,2024

Specifically designed diets demonstrate a 'powerful ability' to prevent tumorigenesis, delay tumor growth

byThe Spanish National Cancer Research CentrePrecision nutrition in cancer therapyPrecision nutrition takes into account genetic, physiological and lifestyle factors to develop personalized diet

Updated on: January 22,2024

Specifically designed diets demonstrate a 'powerful ability' to prevent tumorigenesis, delay tumor growth

byThe Spanish National Cancer Research CentrePrecision nutrition in cancer therapyPrecision nutrition takes into account genetic, physiological and lifestyle factors to develop personalized diet

Updated on:January 22,2024

Researchers exploit DNA amplification in cancer to halt chemoresistance

by Stony Brook UniversityGábor Balázsi, in his Biomedical Engineering laboratory with Rafal Krzysztoń, PhD, and Yiming Wan, PhD, both first co-authors on thePNASpaper. Credit: John Gr

Updated on: June 08,2024

Researchers exploit DNA amplification in cancer to halt chemoresistance

by Stony Brook UniversityGábor Balázsi, in his Biomedical Engineering laboratory with Rafal Krzysztoń, PhD, and Yiming Wan, PhD, both first co-authors on thePNASpaper. Credit: John Gr

Updated on:June 08,2024

Researchers characterize mechanism of action of CAR T cells

by H. Lee Moffitt Cancer Center & Research InstituteScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDThe sci

Updated on: June 08,2024

Researchers characterize mechanism of action of CAR T cells

by H. Lee Moffitt Cancer Center & Research InstituteScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDThe sci

Updated on:June 08,2024